Radar › Companies › Healthcare · Russia
Radar · Healthcare in Russia

Best Healthcare Companies in Russia

The 103 best Healthcare companies in Russia in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Sintez.

103companies tracked
$284.3Mdisclosed funding
0unicorns
9have raised

Russia's Healthcare sector is more active than the headline numbers suggest, and this directory ranks 103 tracked companies by disclosed equity funding and recent momentum to help you cut through the noise fast. Total disclosed funding sits at $284M across those companies, with Sintez leading at $125M, OBL Pharm at $60M, and Nanolek at $44M pulling serious weight. No unicorns yet, but the concentration of capital in pharma and biotech is hard to miss. The global market backdrop gives context: healthcare crossed $2 trillion in 2020 and is forecast to hit $2.6 trillion by 2025 at a 6.3% CAGR, driven by consumer demand for virtual touchpoints and tech-enabled care delivery.

The sector's hot themes right now are vaccine candidates, trials, and immunogenicity, which tracks with where Russian capital is flowing. Mobile is moving too, with median app install growth at roughly +16% YoY across hospital and healthcare distribution apps. I'd also flag that patient trust is becoming a structural issue globally, and Russia's strict product safety compliance requirements make that pressure sharper here than in most markets. Investors like Russian Direct Investment Fund, Rusnano, and Baring Vostok are the ones writing the checks. So if you're mapping this space, start with the funding leaders and work outward.

Sources & further reading
  • Healthcare Consumers in Asia-Pacific Prefer a Single Touchpoint
  • Global Healthcare to Soar Above $2 Trillion in 2020 with Consumerism a

Ranked: Best Healthcare companies in Russia

#CompanyDisclosed fundingLast roundStageFounderFoundedTech stackPatents & IP focusRecent signals
1Sintez
Provider of portfolio of surgical tools
$125M82 mo agoLate StageSergey Klykov
CEO
1958—2 patents
Decentralized blockchain-based crypto monetization and payment processing systems
—
2OBL Pharm
Provider of artist training and film production services
$60M81 mo agoDeadpooledAndrey Mladentsev
CEO & MD
1994———
3Nanolek
Manufacturer of biopharmaceuticals and vaccines
$44M144 mo agoLate StageMikhail Nekrasov
CEO
2011Windows ServerThree.jsGSAP+10——
4JSC "Medicine"
Standalone multi-speciality clinic
$35M169 mo agoSeries BGrigory Efimovich Roytberg
Founder & CEO
19901C-BitrixPHPNginx+17——
5BREFFI
Provider of market research services for biopharma industry
$10M53 mo agoSeries B—2012UbuntuGSAPAngularJS+7——
6TheraMAB
Develop immunotherapeutic monoclonal antibodies (MAbs) for treating diseases in the field of autoimmunity and…
$5M172 mo agoDeadpooled—2009—32 patents
Patents concentrated in chemistry & materials
—
7Genotek
Direct-to-consumer genomic tests
$2M120 mo agoSeedArtem Elmuratov
Co-Founder
2010SentryTypeScriptNode.js+24——
8Rosmed.info
Provider of information and practical portal for doctors and patients
$2M34 mo agoSeries ADenis Vurdov
Founder & CEO
2015PHPYouTubeBootstrap+10——
9Semantic Hub
Provider of AI technology transforming patient stories into structured healthcare knowledge
$971K113 mo agoSeedIrina Efimenko
Co-Founder & CEO
2015———

Top 12 Healthcare companies in Russia

#1
Series A · Moscow, Moscow · founded 2015
$1.5Mraised
▾

Provider of information and practical portal for doctors and patients. It serves as a medical platform that integrates all types of users into a unified online process of collecting and managing medical information for professionals.

Funding rounds
  • Aug 2023Series A$1.5M
Founders & team
Denis VurdovFounder & CEO
#2
Series B · Moscow, Moscow · founded 2012 · 37 employees
$10.2Mraised
▾

Provider of market research services for biopharma industry

Funding rounds
  • Dec 2021Series B$10.2M
Investors
Elbrus Capital
Tech stack
UbuntuAngularjsApache Http ServerGoogle Tag Manager
#3
Late Stage · Kurgan, Kursk Oblast · founded 1958 · 3017 employees
$125.5Mraised
▾

Sintez OJSC provides surgical tools and a portfolio of pharmaceutical products. It offers medicals devices like polymer-based blood infusion, syringe, blood transfusion, single bottles, and others. The company is also involved in the development and manufacturing of products like OTC, generic drugs, veterinary products, and others.

Founders & team
Sergey KlykovCEO
Investors
Sinocom Group, Sistema
#4
Deadpooled · Moscow, Moscow · founded 1994
$60Mraised
▾

Provider of artist training and film production services. It offers comprehensive training programs for aspiring actors, models, singers, and dancers. The curriculum includes acting techniques, movement training, voice coaching, and on-camera experience. Additionally, the company provides film production services, encompassing various aspects from pre-production to post-production. This includes casting, production management, and post-production services such as editing and VFX. The company aims to nurture talent and facilitate its entry into the entertainment industry.

Founders & team
Andrey MladentsevCEO & MD
Investors
Russian Direct Investment Fund, Russia-China Investment Fund, UFG Asset Management
#5
Late Stage · Moscow, Moscow · founded 2011 · 201 employees
$43.7Mraised
▾

Manufacturer of biopharmaceuticals and vaccines. This company specializes in the production of import-substituting drugs for the prevention and treatment of socially significant diseases. It has established a robust research and development center focused on creating new vaccines, from initial active substance development through clinical trials and scaling up for manufacturing. The company also localizes innovative drugs in partnership with major pharmaceutical companies. Its manufacturing facility adheres to global Good Manufacturing Practice (GMP) standards. The company's portfolio includes both oncological and orphan disease treatments.

Funding rounds
  • 2014Conventional Debt$39.8M
  • 2011PE$43.7M
Founders & team
Mikhail NekrasovCEO
Investors
Rusnano, Sberbank
Tech stack
CdnjsCloudflareGsapIisJsdelivrNginx
#6
Series B · Moscow, Moscow · founded 1990 · 300 employees
$35Mraised
▾

Operator of a chain of healthcare clinics in Russia. The company specializes in owning and operating a series of JCI- approved medical clinics enabling patients to get quality medical care at affordable prices from a team of caring staff using the latest healthcare technologies.

Founders & team
Grigory Efimovich RoytbergFounder & CEO
Tech stack
1C-BitrixBabelCdnjsCloudflareCore-JsFancybox
#7
Deadpooled · Moscow, Moscow · founded 2009 · 4 employees
$5Mraised
▾

TheraMAB develops immunotherapeutic monoclonal antibodies (MAbs). These MAbs modulate the activity of T-lymphocytes and may provide new treatment options for diseases in the field of autoimmunity and cancer. Its pipeline product TAB08 is a humanized IgG4 monoclonal antibody specific for the human T-lymphocyte co-stimulatory receptor CD28 which is described as agonistic T-cells stimulation. TheraMAB was founded by the investment fund Bioprocess Capital Ventures and was granted $5M from Skolkovos Innovation Center.

Funding rounds
  • Feb 2012Grant (prize money)$5M
Investors
RVC USA, Bioprocess Capital Partners
#8
Seed · Moscow, Moscow · founded 2010 · 65 employees
$2.4Mraised
▾

Genotek provides direct-to-consumer genomic tests. Customers can order a kit online, mail in their cheek swab and receive results that have been signed off by doctors and genetic counselors. Genotek can test for over 5000 genes and screen for 4500 inherited conditions.

Funding rounds
  • 2016Angel$2M
  • 2013Seed$400K
Founders & team
Artem ElmuratovCo-Founder
Investors
Rustars Ventures, MSU Business Incubator
Tech stack
AngularBabelBitrix24BootstrapCart FunctionalityChart.Js
#9
Seed · Moscow, Moscow · founded 2015 · 21 employees
$970.5Kraised
▾

Provider of AI technology transforming patient stories into structured healthcare knowledge. The company offers analysis of patient journeys, product differentiation, and stakeholder mapping. It delivers patient segmentation, profiling, language samples, and early detection. Additionally, the company focuses on recruitment to clinical trials, engagement, and education.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 2k LinkedIn followers — 14.4% of this cohort's audience
Funding rounds
  • Jan 2017Seed$970.5K
Founders & team
Irina EfimenkoCo-Founder & CEOVladimir KhoroshevskyCo-FounderVitaly NedelskyCo-Founder
Investors
IIDF, XNode
Tech stack
ErlangCowboy
#10
Deadpooled · Moscow, Moscow · founded 2014
$25Kraised
▾

Provider of marketing services designed to offer lead generation services for fitness clubs. The company's services include customer procurement services for fitness clubs by using its online advertising channels, enabling fitness clubs to gain new clients.

Funding rounds
  • Jun 2015Seed$25K
Founders & team
Daniil BityukFounder
Investors
IIDF
#11
Public · Irkutsk, Irkutsk Oblast · founded 1997 · 94 employees
—raised
▾

Pharmsynthez manufactures and markets medicines used in oncology, gynecology, viral diseases, and tuberculosis, and conducts clinical development of therapeutic vaccines and bio superiors. Along with drug development, it also develops methods of drugs’ delivery into the body, and technologies for the production of their ingredients. Manufactures and sells both finished drug products (original FDP) and active pharmaceutical ingredients (API). Has a strategic partnership with Dong-A.

Investors
LDA, Rusnano
Tech stack
AddtoanyAddtoany Share ButtonsAnime.JsCore-JsEwww Image OptimizerGoogle Font Api
#12
Seed · Moscow, Moscow · founded 2000 · 201 employees
—raised
▾

Chain of fitness centers

Investors
Russian Direct Investment Fund, Mubadala
Tech stack
1C-BitrixAdriverBootstrapCart FunctionalityCdnjsClipboard.Js

Funding & investor landscape

$284.3Mtotal disclosed funding
10companies funded
9disclosed rounds
0rounds last 90 days
Most active investors
Russian Direct Investment Fund5 rounds
IIDF3 rounds
Rusnano3 rounds
Baring Vostok2 rounds
CapMan2 rounds
Bioprocess Capital Partners1 rounds
Domain Associates1 rounds
Elbrus Capital1 rounds
Ingria-Startup1 rounds
Japan Bank for International Cooperation1 rounds

Notable founders

Denis Vurdov
Founder & CEO · Rosmed.info
Sergey Klykov
CEO · Sintez
Andrey Mladentsev
CEO & MD · OBL Pharm
Mikhail Nekrasov
CEO · Nanolek
Grigory Efimovich Roytberg
Founder & CEO · JSC "Medicine"
Artem Elmuratov
Co-Founder · Genotek
Irina Efimenko
Co-Founder & CEO · Semantic Hub
Vladimir Khoroshevsky
Co-Founder · Semantic Hub
Daniil Bityuk
Founder · Fitness-Clubs
Foteev Vladimir Gennadievich
Founder & CEO · Medisorb
Alexey Remez
CEO · UNIM
Artem Gapeev
General Director & Ex-CEO · European Medical Center
Prism market signals · Russia · country-scoped Prism corpus, 2,050,251 docs

Market landscape — 10 sub-themes by coverage

Share of Healthcare coverage by sub-theme.

Regulatory-risk over time rising

Funding & growth over time

funding rising · growth rising

Common questions

How many Healthcare companies are there in Russia?
Radar tracks 103 indexable Healthcare companies headquartered in Russia that meet our profile-completeness bar.
What is the total funding raised by Healthcare companies in Russia?
The Healthcare companies in Russia on this list have raised a combined $284.3M in disclosed equity funding across 10 funded companies.
Which is the highest-funded Healthcare company in Russia?
Sintez is the highest-funded Healthcare company in Russia, with $125.5M in disclosed equity funding.
How many Healthcare companies in Russia are funded?
10 of the 103 Healthcare companies in Russia on this list have disclosed at least one equity funding round.
How many Healthcare unicorns are there in Russia?
None of the Healthcare companies in Russia on this list currently has a disclosed valuation of $1B or more.
Who are the top investors in Russia Healthcare companies?
The most active investors in Russia Healthcare companies on this list include Russian Direct Investment Fund, IIDF, Rusnano, Baring Vostok, CapMan.
Rohit KhannaTrends & Stories

Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.

Coming soon